C
Rigel Pharmaceuticals, Inc. RIGL
$44.41 -$2.85-6.03% NASDAQ
Recommendation
Prev Close
$44.41
Volume
3,122
Avg Vol (90D)
698,498
Market Cap
$806.10M
Dividend & Yield
--
52-Week Range
$14.63 - $52.24
P/E (TTM)
7.20
EPS (TTM)
$6.17
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Rigel Pharmaceuticals (RIGL, $47.26) RSI Indicator left the overbought zone on December 01, 2025
12/2/2025 - Tickeron - Stocks
Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue?
11/27/2025 - Zacks Investment Research
If EPS Growth Is Important To You, Rigel Pharmaceuticals (NASDAQ:RIGL) Presents An Opportunity
11/27/2025 - Simply Wall St
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives $43.20 Consensus PT from Brokerages
11/27/2025 - Zolmax
Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference
11/26/2025 - PR Newswire
Rigel Pharmaceuticals: Behind The Huge Rally
11/25/2025 - SeekingAlpha
Rigel Pharmaceuticals (NASDAQ:RIGL) Hits New 52-Week High - Time to Buy?
11/25/2025 - MarketBeat
First Week of January 2026 Options Trading For Rigel Pharmaceuticals (RIGL)
11/25/2025 - Stock Options Channel
Rigel Pharmaceuticals (RIGL, $49.8) price may drop as it broke higher Bollinger Band on Nov 24, 2025
11/25/2025 - Tickeron - Stocks
76,870 Shares in Rigel Pharmaceuticals, Inc. $RIGL Acquired by Brandywine Global Investment Management LLC
11/25/2025 - MarketBeat
37,269 Shares in Rigel Pharmaceuticals, Inc. $RIGL Acquired by Sierra Summit Advisors LLC
11/24/2025 - MarketBeat
Rigel Pharmaceuticals Reaches Analyst Target Price
11/24/2025 - ETF Channel
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Recommendation of "Moderate Buy" from Analysts
11/24/2025 - MarketBeat
Rigel Pharmaceuticals, Inc. $RIGL Stake Boosted by Hillsdale Investment Management Inc.
11/23/2025 - MarketBeat
LSV Asset Management Buys Shares of 95,700 Rigel Pharmaceuticals, Inc. $RIGL
11/23/2025 - MarketBeat
Rigel Pharmaceuticals (RIGL, $46.22) RSI Indicator left the overbought zone on November 21, 2025
11/22/2025 - Tickeron - Stocks
Rigel Pharmaceuticals (NASDAQ:RIGL) Trading Down 8% - Time to Sell?
11/22/2025 - Ticker Report
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Up 5% - Still a Buy?
11/21/2025 - MarketBeat
Rigel Pharmaceuticals (NASDAQ:RIGL) Shares Up 5% - Still a Buy?
11/20/2025 - Ticker Report
Rigel Pharmaceuticals (NASDAQ:RIGL) Trading Down 8% - Here's What Happened
11/20/2025 - MarketBeat
Rigel Pharmaceuticals (RIGL, $41.68) RSI Indicator left the overbought zone on November 19, 2025
11/20/2025 - Tickeron - Stocks
Rigel Pharmaceuticals (NASDAQ:RIGL) Sets New 12-Month High - Here's What Happened
11/19/2025 - MarketBeat
Rigel Pharmaceuticals (NASDAQ:RIGL) Sets New 12-Month High - Here's What Happened
11/18/2025 - Ticker Report
Commit To Buy Rigel Pharmaceuticals At $27, Earn 16.3% Annualized Using Options
11/18/2025 - Stock Options Channel
Rigel Pharmaceuticals (RIGL) Publishes Five-Year Data on Rezlidhia for AML
11/17/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$282.08M
EBITDA (TTM)
$121.37M
EBIT (TTM)
$118.95M
Net Income (TTM)
$113.30M
Balance Sheet
Total Assets (Q)
$242.53M
Total Debt (Q)
$60.88M
Total Liabilities (Q)
$124.93M
Book Value Per Share (Q)
$6.48
Cash Flow
Cash from Operations (TTM)
$68.18M
Cash from Investing (TTM)
-$77.92M
Cash from Financing (TTM)
$6.64M
Net Change in Cash (TTM)
-$3.10M
Filings
Filing Date
Tuesday, November 4, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 2 and 6 (est)
Price History
Loading...
Beta
1.46
7-Day Total Return
-3.91%
30-Day Total Return
46.71%
60-Day Total Return
23.60%
90-Day Total Return
122.16%
Year to Date Total Return
156.41%
1-Year Total Return
64.18%
2-Year Total Return
311.20%
3-Year Total Return
367.47%
5-Year Total Return
47.54%
52-week Low
Dec 24, 2024 - $14.63
52-week High
Nov 28, 2025 - $52.24
Valuation
Market Cap
$806.10M - Small Cap
Enterprise Value
$729.84M
Price/Sales (TTM)
3.02
Price/Book (Q)
6.85
Dividends and Shares
Shares Outstanding
19.16
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.rigel.com
Phone Number
650 624 1100
Address
611 Gateway Boulevard
South San Francisco, CA 94080
Country
United States
Year Founded
1996
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer. The... more
NASDAQ 12/02/2025 4:00PM Eastern Quotes delayed